Breaking News Instant updates and real-time market news.

SYNC

Synacor

$1.51

-0.035 (-2.27%)

, T

AT&T

$33.46

-0.3 (-0.89%)

09:06
07/12/19
07/12
09:06
07/12/19
09:06

Synacor talks with AT&T would remove largest headwind, says Craig-Hallum

Craig-Hallum analyst George Sutton upgraded Synacor (SYNC) to Buy from Hold with a $2.00 price target after the company said it has started discussions to wind-down its portal services with AT&T (T). In a research note to investors, Sutton says views this move this as the removal of the largest headwind facing the stock and believes investors will be able to fully recognize the remaining value of the software and advertising segments, which are reflected in his updated FY20 estimate of $100M.

SYNC

Synacor

$1.51

-0.035 (-2.27%)

T

AT&T

$33.46

-0.3 (-0.89%)

  • 24

    Jul

  • 30

    Jul

  • 08

    Aug

  • 12

    Sep

SYNC Synacor
$1.51

-0.035 (-2.27%)

08/02/18
LSCM
08/02/18
NO CHANGE
Target $3
LSCM
Buy
Synacor shares are 'worth revisiting,' says Lake Street
Lake Street analyst Mark Argento says shares of Synacor (SYNC) are "worth revisiting" as the story becomes less about AT&T (T) and more about higher margin recurring revenues. The company posted another solid quarter, Argento tells investors in a post-earnings research note. He keeps a Buy rating on Synacor with a $3 price target.
11/09/18
RSBL
11/09/18
DOWNGRADE
RSBL
Neutral
Synacor downgraded to Neutral from Buy at Rosenblatt
07/12/19
CHLM
07/12/19
UPGRADE
CHLM
Buy
Synacor upgraded to Buy from Hold at Craig-Hallum
Craig-Hallum analyst George Sutton upgraded Synacor to Buy from Hold.
07/12/19
NEED
07/12/19
NO CHANGE
NEED
Hold
Synacor's lost AT&T deal accounts for 25% of its revenue, says Needham
Needham analyst Laura Martin is keeping her Hold rating on Synacor (SYNC) but notes that the company is losing about 25% of its revenue after announcing that it is winding down its ATT.net portal services deal with AT&T (T). The analyst believes that the FY19 financial impact of that loss will amount to about $40M in revenue and $5M in expected EBITDA.
T AT&T
$33.46

-0.3 (-0.89%)

06/10/19
JPMS
06/10/19
NO CHANGE
Target $38
JPMS
Overweight
AT&T, Dish satellite video combination would make sense, says JPMorgan
It would make sense for AT&T (T) and Dish (DISH) to combine video operations, nearly two decades after an attempt failed in 2002, JPMorgan analyst Philip Cusick tells investors in a research note after press reports discussed a combination of Dish and DirecTV. The analyst believes the dis-synergies of pulling DirecTV away from AT&T's U-verse "in buying power would be value destructive." The analyst, however, does not think the companies are in discussions today, and he sees both "regulatory and personality issues that would have to be overcome to get to a deal." He reiterates Overweight ratings on AT&T and Dish and notes his price targets of $38 from $40, respectively, reflect no potential deal.
07/08/19
JPMS
07/08/19
DOWNGRADE
JPMS
Neutral
JPMorgan downgrades BCE to Neutral, Rogers to Underweight
JPMorgan analyst Richard Choe downgraded BCE (BCE) to Neutral from Overweight and Rogers Communications (RCI) to Underweight from Neutral. The analyst cut his price target for BCE to C$60 from C$63 and for Rogers to C$69 from C$71. Choe also reduced his price target for Neutral-rated Telus (TU) to C$49 from $C51. Rogers on June 12 announced the launch of its unlimited plan offering for its premium postpaid brand and BCE as well as Telus quickly followed, Choe tells investors in a research note. The analyst says he's starting to see a slowdown in subscriber growth. In addition, potential average revenue per user pressure from the migration to unlimited plans creates risk to the premium multiples the Canadian Communications companies have traded at versus U.S. and global peers, contends the analyst. He recommends stepping away from Canadian carriers at this level and prefers AT&T (T) and Comcast (CMCSA) in the U.S.
07/08/19
SBSH
07/08/19
DOWNGRADE
Target $62
SBSH
Neutral
Citi downgrades Verizon to Neutral on rising long-term industry risks
Citi analyst Michael Rollins downgraded Verizon Communications (VZ) to Neutral from Buy with an unchanged price target of $62. Rising long-term industry risks and the stock's current valuation premium are likely to limit returns over the next 12-months, Rollins tells investors in a research note. He believes long-term risks are rising for industry pricing and margins given the "widening array of possible outcomes" for the proposed merger of T-Mobile (TMUS) and Sprint (S). Rollins thinks national wireless firms that take more aggressive steps to shape their long-term strategic and competitive position in the industry have a better chance of creating value over the next 12-months. As such, he maintains Buy ratings on T-Mobile, AT&T (T), Telephone and Data (TDS) and U.S. Cellular (USM).

TODAY'S FREE FLY STORIES

NFLX

Netflix

$325.14

-37.36 (-10.31%)

, DIS

Disney

$141.62

-0.97 (-0.68%)

08:54
07/19/19
07/19
08:54
07/19/19
08:54
Recommendations
Netflix, Disney analyst commentary  »

Netflix sub losses are…

NFLX

Netflix

$325.14

-37.36 (-10.31%)

DIS

Disney

$141.62

-0.97 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

DB

Deutsche Bank

$7.93

0.05 (0.63%)

08:47
07/19/19
07/19
08:47
07/19/19
08:47
Conference/Events
Deutsche Bank to hold a conference call »

Management holds the 2Q19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 26

    Jul

SPY

SPDR S&P 500 ETF Trust

$298.86

1.07 (0.36%)

, SPX

S&P 500

$0.00

(0.00%)

08:46
07/19/19
07/19
08:46
07/19/19
08:46
General news
Trump says Federal Reserve thought process 'faulty' »

President Donald Trump…

SPY

SPDR S&P 500 ETF Trust

$298.86

1.07 (0.36%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$6.44

-0.12 (-1.83%)

, BZUN

Baozun

$50.05

0.05 (0.10%)

08:45
07/19/19
07/19
08:45
07/19/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

APHA

Aphria

$6.44

-0.12 (-1.83%)

BZUN

Baozun

$50.05

0.05 (0.10%)

CGC

Canopy Growth

$35.79

-0.78 (-2.13%)

UBER

Uber

$43.70

0.08 (0.18%)

PETS

PetMed Express

$16.27

-0.68 (-4.01%)

LK

Luckin Coffee

$19.96

0.46 (2.36%)

ESTC

Elastic

$97.78

1.82 (1.90%)

TECK

Teck Resources

$22.01

-0.21 (-0.95%)

DUST

Direxion Daily Gold Miners Bear 3X ETF

$8.06

-1.2 (-12.96%)

DDS

Dillard's

$64.05

-0.3 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 25

    Jul

  • 26

    Jul

  • 01

    Aug

  • 08

    Aug

YGYI

Youngevity

$4.97

-0.22 (-4.24%)

08:40
07/19/19
07/19
08:40
07/19/19
08:40
Hot Stocks
Youngevity's Khrysos Industries closes $19M supply agreement »

Youngevity executed a one…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$71.79

0.95 (1.34%)

08:38
07/19/19
07/19
08:38
07/19/19
08:38
Conference/Events
Citi to host conference call »

CFO Mason & Treasurer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 15

    Oct

SYDDF

Sydney Airport

$0.00

(0.00%)

08:37
07/19/19
07/19
08:37
07/19/19
08:37
Initiation
Sydney Airport initiated at JPMorgan »

Sydney Airport initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEAS

SeaWorld

$33.81

0.38 (1.14%)

08:37
07/19/19
07/19
08:37
07/19/19
08:37
Hot Stocks
SeaWorld elects Charles Koppelman as director, announces board changes »

SeaWorld's Board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

GILD

Gilead

$67.22

0.31 (0.46%)

, NVS

Novartis

$94.30

4.185 (4.64%)

08:37
07/19/19
07/19
08:37
07/19/19
08:37
Hot Stocks
Gilead licenses three preclinical antiviral programs from Novartis »

Gilead (GILD) announced…

GILD

Gilead

$67.22

0.31 (0.46%)

NVS

Novartis

$94.30

4.185 (4.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 22

    Jul

  • 23

    Jul

  • 30

    Jul

  • 07

    Aug

  • 09

    Sep

  • 25

    Sep

BCSF

Bain Capital Specialty Finance

$18.02

-0.06 (-0.33%)

08:35
07/19/19
07/19
08:35
07/19/19
08:35
Hot Stocks
Bain Capital Specialty Finance expands board to 7 directors from 5 directors »

Bain Capital Specialty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

SYF

Synchrony

$36.09

0.54 (1.52%)

, PYPL

PayPal

$119.87

1.07 (0.90%)

08:35
07/19/19
07/19
08:35
07/19/19
08:35
Hot Stocks
Synchrony says average active accounts up 9% in Q2 »

Synchrony (SYF) says it…

SYF

Synchrony

$36.09

0.54 (1.52%)

PYPL

PayPal

$119.87

1.07 (0.90%)

WMT

Walmart

$114.68

0.08 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 24

    Jul

  • 15

    Aug

  • 25

    Sep

  • 13

    Nov

SMSI

Smith Micro

$3.12

0.04 (1.30%)

08:35
07/19/19
07/19
08:35
07/19/19
08:35
Initiation
Smith Micro initiated at B. Riley FBR »

B. Riley FBR starts Smith…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

UNP

Union Pacific

$174.15

10.1 (6.16%)

08:35
07/19/19
07/19
08:35
07/19/19
08:35
Recommendations
Union Pacific analyst commentary at Loop Capital »

Union Pacific price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

MRKR

Marker Therapeutics

$8.68

-0.01 (-0.12%)

08:35
07/19/19
07/19
08:35
07/19/19
08:35
Conference/Events
Marker Therapeutics to hold a conference call »

Management reviews data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 09

    Sep

AMRS

Amyris

$2.91

-0.03 (-1.02%)

08:35
07/19/19
07/19
08:35
07/19/19
08:35
Hot Stocks
Amyris expands contract with ADL Bionatur to 2020 »

Amyris has expanded its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

DHR

Danaher

$143.03

3.43 (2.46%)

08:34
07/19/19
07/19
08:34
07/19/19
08:34
Recommendations
Danaher analyst commentary at Baird »

Danaher price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

STAF

Staffing 360 Solutions

$1.74

0.025 (1.46%)

08:32
07/19/19
07/19
08:32
07/19/19
08:32
Hot Stocks
Staffing 360 Solutions opens new office in Shelton, Connecticut »

Staffing 360 Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RGLD

Royal Gold

$117.56

4.19 (3.70%)

08:32
07/19/19
07/19
08:32
07/19/19
08:32
Recommendations
Royal Gold analyst commentary at B. Riley FBR »

Royal Gold price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

HBAN

Huntington Bancshares

$13.76

0.18 (1.33%)

08:32
07/19/19
07/19
08:32
07/19/19
08:32
Hot Stocks
Huntington Bancshares increases quarterly cash dividend 7% to 15c per share »

Huntington Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 29

    Aug

PETX

Aratana Therapeutics

$4.93

(0.00%)

08:30
07/19/19
07/19
08:30
07/19/19
08:30
Options
One option delisting on July 19th »

Option delistings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCK

Crown Holdings

$59.50

0.12 (0.20%)

08:29
07/19/19
07/19
08:29
07/19/19
08:29
Recommendations
Crown Holdings analyst commentary at Baird »

Crown Holdings shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBIO

Harvard Bioscience

$1.78

0.03 (1.71%)

08:29
07/19/19
07/19
08:29
07/19/19
08:29
Recommendations
Harvard Bioscience analyst commentary at Benchmark »

Harvard Bioscience CFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HON

Honeywell

$173.86

5.05 (2.99%)

08:28
07/19/19
07/19
08:28
07/19/19
08:28
Recommendations
Honeywell analyst commentary at Jefferies »

Honeywell price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

TSM

TSMC

$43.21

1.59 (3.82%)

08:28
07/19/19
07/19
08:28
07/19/19
08:28
Upgrade
TSMC rating change  »

TSMC upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$361.17

-8.28 (-2.24%)

08:26
07/19/19
07/19
08:26
07/19/19
08:26
Recommendations
Boeing analyst commentary at Jefferies »

Boeing price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.